Al-'Aqar Healthcare REIT (KLSE:ALAQAR)
Malaysia · Delayed Price · Currency is MYR 1.171
0.00 (0.00%)
At close: Jun 9, 2026
Al-'Aqar Healthcare REIT Income Statement
Financials in millions MYR. Fiscal year is January - December.
Millions MYR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Rental Revenue | 123.74 | 119.96 | 117.22 | 121.02 | 110.24 | 114.07 |
Gain (Loss) on Sale of Assets (Rev) | -2 | -2 | -15.57 | - | - | - |
Other Revenue | 0.53 | 0.53 | 0.64 | 0.73 | 1.01 | 0.53 |
| 124.21 | 120.34 | 104.17 | 123.2 | 112.17 | 115.23 | |
Revenue Growth (YoY | 19.86% | 15.53% | -15.45% | 9.84% | -2.66% | -2.46% |
Property Expenses | 13.93 | 14.11 | 13.32 | 12.6 | 10.17 | 9.96 |
Selling, General & Administrative | 3.33 | 3.11 | 4.08 | 5.35 | 2.49 | 3.4 |
Total Operating Expenses | 17.25 | 17.23 | 17.4 | 17.95 | 12.66 | 13.36 |
Operating Income | 106.96 | 103.11 | 86.77 | 105.26 | 99.51 | 101.87 |
Interest Expense | -43.21 | -40.87 | -38.61 | -39.15 | -27.6 | -28 |
Currency Exchange Gain (Loss) | -0.03 | -0.03 | -0.13 | 0.06 | -0.07 | -0.14 |
Other Non-Operating Income | -0.01 | -0.01 | -0.01 | -0.02 | -0.01 | -0.01 |
EBT Excluding Unusual Items | 63.72 | 62.21 | 48.02 | 66.15 | 71.83 | 73.73 |
Gain (Loss) on Sale of Assets | - | - | - | - | -0.09 | - |
Asset Writedown | -6.45 | -6.45 | 10.13 | -5.15 | -11.26 | 5.54 |
Other Unusual Items | - | - | - | - | - | -5.81 |
Pretax Income | 57.27 | 55.76 | 58.15 | 61 | 60.48 | 73.46 |
Income Tax Expense | 0.04 | 0.04 | -0.12 | 0.31 | 0.34 | -0.09 |
Net Income | 57.23 | 55.72 | 58.27 | 60.69 | 60.14 | 73.55 |
Net Income to Common | 57.23 | 55.72 | 58.27 | 60.69 | 60.14 | 73.55 |
Net Income Growth | -0.75% | -4.39% | -3.99% | 0.92% | -18.23% | 485.06% |
Basic Shares Outstanding | 840 | 840 | 840 | 815 | 736 | 736 |
Diluted Shares Outstanding | 840 | 840 | 840 | 815 | 736 | 736 |
Shares Change (YoY) | 0.04% | - | 3.05% | 10.66% | 0.04% | - |
EPS (Basic) | 0.07 | 0.07 | 0.07 | 0.07 | 0.08 | 0.10 |
EPS (Diluted) | 0.07 | 0.07 | 0.07 | 0.07 | 0.08 | 0.10 |
EPS Growth | -0.79% | -4.39% | -6.82% | -8.80% | -18.27% | 485.05% |
Dividend Per Share | 0.071 | 0.071 | 0.073 | 0.079 | 0.081 | 0.078 |
Dividend Growth | 31.47% | -2.89% | -7.98% | -2.47% | 3.85% | 14.54% |
Operating Margin | 86.11% | 85.68% | 83.30% | 85.43% | 88.72% | 88.41% |
Profit Margin | 46.07% | 46.30% | 55.94% | 49.26% | 53.62% | 63.83% |
EBIT | 106.96 | 103.11 | 86.77 | 105.26 | 99.51 | 101.87 |
EBIT Margin | 86.11% | 85.68% | 83.30% | 85.43% | 88.72% | 88.41% |
Effective Tax Rate | 0.08% | 0.08% | - | 0.50% | 0.57% | - |
Revenue as Reported | - | - | - | - | 94.87 | 114.92 |